Search
Citations et références (10)
Invitrogen™
Lectin PNA From Arachis hypogaea (peanut), Alexa Fluor™ 594 Conjugate
Lectin PNA is specific for terminal β-galactose. It will agglutinate human erythrocytes, but only after neuraminidase treatment.View complete list ofAfficher plus
| Référence | Quantité |
|---|---|
| L32459 | 1 mg |
Référence L32459
Prix (EUR)
260,00
Each
Quantité:
1 mg
Prix (EUR)
260,00
Each
Lectin PNA is specific for terminal β-galactose. It will agglutinate human erythrocytes, but only after neuraminidase treatment.
View complete list of fluorescent dye-conjugated lectins ›
View complete list of fluorescent dye-conjugated lectins ›
For Research Use Only. Not for use in diagnostic procedures.
Spécifications
Type d’étiquetteAlexa Fluor Dyes
Gamme de produitsAlexa Fluor
Sous-type de protéineLectins
Quantité1 mg
Conditions d’expéditionRoom Temperature
SourcePeanut
ConjuguéAlexa Fluor 594
FormeLyophilized
Unit SizeEach
Contenu et stockage
Store in freezer (-5 to -30°C) and protect from light.
Citations et références (10)
Citations et références
Abstract
Localization of sphingosine kinase-1 in mouse sperm acrosomes.
Journal:J Histochem Cytochem
PubMed ID:15684337
Sphingosine kinase (SPHK) catalyzes sphingosine phosphorylation to form a bioactive lipid mediator, sphingosine-1-phosphate (S1P). In the current study, we report the presence of SPHK-1 in mouse spermatozoa. SPHK-1 was localized to the acrosomes of spermatozoa, and its expression was proven by RT-PCR and Western blot analysis. SPHK activity of mouse
Substantial restoration of night vision in adult mice with congenital stationary night blindness.
Journal:Mol Ther Methods Clin Dev
PubMed ID:34401402
Shared developmental programme strongly constrains beak shape diversity in songbirds.
Journal:Nat Commun
PubMed ID:24739280
Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation.
Journal:Stem Cell Reports
PubMed ID:31155505
Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy.
Journal:PLoS One
PubMed ID:24671090